These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30734016)

  • 1. International comparison of treatment strategy and survival in metastatic gastric cancer.
    Claassen YHM; Bastiaannet E; Hartgrink HH; Dikken JL; de Steur WO; Slingerland M; Verhoeven RHA; van Eycken E; de Schutter H; Lindblad M; Hedberg J; Johnson E; Hjortland GO; Jensen LS; Larsson HJ; Koessler T; Chevallay M; Allum WH; van de Velde CJH
    BJS Open; 2019 Feb; 3(1):56-61. PubMed ID: 30734016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis.
    Claassen YHM; Dikken JL; Hartgrink HH; de Steur WO; Slingerland M; Verhoeven RHA; van Eycken E; de Schutter H; Johansson J; Rouvelas I; Johnson E; Hjortland GO; Jensen LS; Larsson HJ; Allum WH; Portielje JEA; Bastiaannet E; van de Velde CJH
    Eur J Surg Oncol; 2018 Dec; 44(12):1982-1989. PubMed ID: 30343998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International benchmarking in oesophageal and gastric cancer surgery.
    Busweiler LAD; Jeremiasen M; Wijnhoven BPL; Lindblad M; Lundell L; van de Velde CJH; Tollenaar RAEM; Wouters MWJM; van Sandick JW; Johansson J; Dikken JL
    BJS Open; 2019 Feb; 3(1):62-73. PubMed ID: 30734017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.
    Fujitani K; Yang HK; Mizusawa J; Kim YW; Terashima M; Han SU; Iwasaki Y; Hyung WJ; Takagane A; Park DJ; Yoshikawa T; Hahn S; Nakamura K; Park CH; Kurokawa Y; Bang YJ; Park BJ; Sasako M; Tsujinaka T;
    Lancet Oncol; 2016 Mar; 17(3):309-318. PubMed ID: 26822397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in outcomes of oesophageal and gastric cancer surgery across Europe.
    Dikken JL; van Sandick JW; Allum WH; Johansson J; Jensen LS; Putter H; Coupland VH; Wouters MW; Lemmens VE; van de Velde CJ; van der Geest LG; Larsson HJ; Cats A; Verheij M
    Br J Surg; 2013 Jan; 100(1):83-94. PubMed ID: 23180474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of age on rates of palliative surgery and chemotherapy use in patients with locally advanced or metastatic gastric cancer.
    Nelen SD; van Putten M; Lemmens VEPP; Bosscha K; de Wilt JHW; Verhoeven RHA
    Br J Surg; 2017 Dec; 104(13):1837-1846. PubMed ID: 28791679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall survival before and after centralization of gastric cancer surgery in the Netherlands.
    van Putten M; Nelen SD; Lemmens VEPP; Stoot JHMB; Hartgrink HH; Gisbertz SS; Spillenaar Bilgen EJ; Heisterkamp J; Verhoeven RHA; Nieuwenhuijzen GAP
    Br J Surg; 2018 Dec; 105(13):1807-1815. PubMed ID: 30132789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.
    de Steur WO; Hartgrink HH; Dikken JL; Putter H; van de Velde CJ
    Br J Surg; 2015 Oct; 102(11):1388-93. PubMed ID: 26313463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
    Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
    Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric cancer: an audit of 122 consecutive cases and the results of R1 gastrectomy.
    Irvin TT; Bridger JE
    Br J Surg; 1988 Feb; 75(2):106-9. PubMed ID: 3349292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operative mortality after gastric cancer resection and long-term survival differences across Europe.
    Lepage C; Sant M; Verdecchia A; Forman D; Esteve J; Faivre J;
    Br J Surg; 2010 Feb; 97(2):235-9. PubMed ID: 20069605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
    Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
    Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor compliance with perioperative chemotherapy for resectable gastric cancer and its impact on survival.
    van Putten M; Lemmens VEPP; van Laarhoven HWM; Pruijt HFM; Nieuwenhuijzen GAP; Verhoeven RHA
    Eur J Surg Oncol; 2019 Oct; 45(10):1926-1933. PubMed ID: 30982656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of hospital type on outcomes after oesophageal and gastric cancer surgery.
    Dikken JL; Wouters MW; Lemmens VE; Putter H; van der Geest LG; Verheij M; Cats A; van Sandick JW; van de Velde CJ
    Br J Surg; 2012 Jul; 99(7):954-63. PubMed ID: 22569956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
    Zhu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based study of diagnosis, treatment and prognosis of gastric cancer.
    Msika S; Tazi MA; Benhamiche AM; Couillault C; Harb M; Faivre J
    Br J Surg; 1997 Oct; 84(10):1474-8. PubMed ID: 9361617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
    Messager M; de Steur WO; van Sandick JW; Reynolds J; Pera M; Mariette C; Hardwick RH; Bastiaannet E; Boelens PG; van deVelde CJ; Allum WH;
    Eur J Surg Oncol; 2016 Jan; 42(1):116-22. PubMed ID: 26461256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies and overall survival for incurable metastatic colorectal cancer - A EURECCA international comparison including 21,196 patients from the Netherlands and Norway.
    Breugom AJ; Bastiaannet E; Guren MG; Kørner H; Boelens PG; Dekker FW; Kapiteijn E; Gelderblom H; Larsen IK; Liefers GJ; van de Velde CJH
    Eur J Surg Oncol; 2020 Jun; 46(6):1167-1173. PubMed ID: 32151531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the role of nodal ratio as a prognostic factor for gastric cancer nowadays? Comparison with new TNM staging system and analysis according to the number of resected nodes.
    Aurello P; Catracchia V; Petrucciani N; D'Angelo F; Leonardo G; Picchetto A; Antolino L; Magistri P; Terrenato I; Lauro A; Ramacciato G
    Am Surg; 2013 May; 79(5):483-91. PubMed ID: 23635583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of gastric cancer in the elderly: a population-based evaluation of the Munich Cancer Registry.
    Schlesinger-Raab A; Mihaljevic AL; Egert S; Emeny R; Jauch KW; Kleeff J; Novotny A; Nüssler NC; Rottmann M; Schepp W; Schmitt W; Schubert-Fritschle G; Weber B; Schuhmacher C; Engel J
    Gastric Cancer; 2016 Jul; 19(3):713-22. PubMed ID: 26260874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.